4,4,5,5-Tetramethyl-2-((E)-propenyl)[1,3,2]dioxaborolane, 95%, 1g

(S)-((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl) 4-methylbenzenesulfinate, 98%, 100g

(E)-1-Methoxy-4-(4-nitrostyryl)benzene, 98%, 1g

ortho-Phosphoric acid D3 85% solution, in D2O, 99 atom%D, 25 ml, glass packaging

4-Bromo-1-difluoromethyl-2-fluorobenzene, 95.0%, 25g

METHYL 4-TERT-BUTYLDIMETHYLSILYLOXY-2-BUTYNOATE, 95.0%, 250mg

1-Cyclopentyl-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-6-(4-(MorpholinoMethyl)phenyl)-1H-indazole-4-carboxaMide, 98%, 5mg

methyl 2-benzyl-5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxylate, 95%, 1g

2-amino-1-(4-ethylphenyl)ethanol, 95.0%, 250mg

[4-(Dimethylamino)phenyl](pyridin-2-yl)methanol, 98.0%, 250mg

3-[1-(2-Pyridin-4-yl-ethyl)-piperidin-4-yl]propan-1-ol, 250mg

2-Amino-5-iodonicotinonitrile, 97%, 100mg

7-Benzyl-3-thia-7-azabicyclo[3.3.1]nonan-9-one, 98%, 1g